Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11-20190----1件: 93 💬
211C-CSar----2件: 93, 94 💬
313-15mg/kg/d Ursodeoxycholic----1件: 93 💬
418-22mg/kg/d Ursodeoxycholic----1件: 93 💬
52mg CS0159----1件: 93 💬
63 mg [14C]-A4250 capsule----3件: 93, 297, 338 💬
73-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-----1件: 93 💬
83-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic acid----1件: 93 💬
93a,7a-dihydroxy-6a-ethyl-5betacholan-24-oic acid----1件: 93 💬
103a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid----1件: 93 💬
116 alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747----1件: 93 💬
126?-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
136a-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
146a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid----1件: 93 💬
156a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
166a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
176a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
186a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
196a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid----1件: 93 💬
206a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
216a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
226a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
236a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
24[14C]CS0159----1件: 93 💬
25[GFT505]----1件: 93 💬
26[GKT137831]----1件: 93 💬
27[GSK2330672]----1件: 93 💬
28[INT-747, OCA]----1件: 93 💬
29[LY3009104]----4件: 46, 49, 93, 107 💬
30[MBX-8025]----1件: 93 💬
31[MXB-8025]----1件: 93 💬
32[RhuDex choline salt]1件: Choline1件: Choline 💬 --1件: 93 💬
33[volixibat]1件: Volixibat2件: Volixibat potassium ,
Volixibat 💬 		--1件: 93 💬
34A11HA02----1件: 93 💬
35A4250----4件: 93, 296, 297, 338 💬
36Abatacept1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		14件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬28件: 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
37ACIDO OBETICOLICO----3件: 93, 94, 296 💬
38Acido ursodessicolico----1件: 93 💬
39Alkaline Phosphatase1件: Alkaline Phosphatase---4件: 46, 93, 97, 172 💬
40Alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747----1件: 93 💬
41APD334----5件: 93, 96, 97, 98, 269 💬
42ASC42 10 mg----1件: 93 💬
43ASC42 15 mg----1件: 93 💬
44ASC42 5 mg----1件: 93 💬
45Atorvastatin1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬21件: 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
46Azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--26件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
47Babaodan Capsule----1件: 93 💬
48Baricitinib1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬24件: 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
49BCD-085----2件: 93, 271 💬
50Bezafibrat----1件: 93 💬
51Bezafibrat Genericon retard 400 mg----1件: 93 💬
52Bezafibrate1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
53Bezafibrate 100 mg1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
54Bezafibrate 200 MG1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
55Bezafibrate 200 mg in addition to UDCA therapy1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
56Bezafibrate 200 MG Oral Tablet1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
57Bezafibrate 400 MG1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
58Bezafibrate 400 mg in addition to UDCA therapy1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
59Bezafibrate IR1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
60Bezafibrate SR1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
61Bezafibrate, Beza, BZF, Bezalip1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
62Bezafibrate, Beza, BZF, Bezalip mono1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
63Bezafilbrate IR----1件: 93 💬
64Bezalip----2件: 93, 94 💬
65Bezalip mono----1件: 93 💬
66Biological: mesenchymal stem cell----1件: 93 💬
67Blood Draws----1件: 93 💬
68Budenofalk 3mg----2件: 93, 97 💬
69BUDESONIDE1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬10件: 66, 93, 94, 95, 96, 97, 98, 223, 228, 299 💬
70Calcium1件: Calcium---39件: 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
71Choline1件: Choline1件: Choline 💬 --4件: 93, 171, 193, 299 💬
72Cilofexor1件: Cilofexor---2件: 93, 94 💬
73CNP-104----1件: 93 💬
74CNTO1275----6件: 46, 49, 84, 93, 96, 97 💬
75Colchicine1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬9件: 2, 42, 46, 50, 56, 93, 97, 210, 266 💬
76Combination antiviral therapy----1件: 93 💬
77CR845 1.0 mg----1件: 93 💬
78CRC (A3384)----3件: 93, 297, 338 💬
79CS0159----2件: 93, 94 💬
80Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
81Cyclosporin A----12件: 46, 49, 53, 54, 56, 60, 63, 93, 95, 113, 164, 222 💬
82Denosumab1件: Denosumab1件: Denosumab 💬 1件: TNFSF11 💬 8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬11件: 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬
83E6011----4件: 46, 93, 96, 97 💬
84EDP-305----1件: 93 💬
85EDP-305 Dose 1----1件: 93 💬
86EDP-305 Dose 2----1件: 93 💬
87ELAFIBRANOR1件: Elafibranor1件: Elafibranor 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
88Elafibranor 120 mg1件: Elafibranor1件: Elafibranor 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
89Elafibranor 80 mg1件: Elafibranor1件: Elafibranor 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
90Elafibranor 80mg1件: Elafibranor1件: Elafibranor 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
91Emtricitabine1件: Emtricitabine1件: Emtricitabine 💬 --5件: 13, 25, 93, 265, 325 💬
92Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)3件: Emtricitabine,
Tenofovir,
Tenofovir disoproxil		5件: Emtricitabine ,
Tenofovir disoproxil fumarate ,
Tenofovir ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬 		--1件: 93 💬
93EP547----2件: 93, 94 💬
94EP547 Tablet 25mg----2件: 93, 94 💬
95EP547 Tablet 75mg----2件: 93, 94 💬
96Experimental: Seladelpar / MBX-8025 200 mg1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
97Experimental: Seladelpar / MBX-8025 50 mg1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
98Ezetimibe1件: Ezetimibe1件: Ezetimibe 💬 1件: NPC1L1 💬 1件: Fat digestion and absorption 💬5件: 49, 79, 93, 149, 260 💬
99EZETROL----3件: 79, 93, 260 💬
100EZT----1件: 93 💬
101FDC tablet (OCA 5 mg + BZF 400 mg SR)----1件: 93 💬
102Fecal microbiota1件: Fecal microbiota---14件: 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
103Fenofibrate1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬6件: 8, 79, 93, 94, 97, 265 💬
104Fenofibrate 200mg1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
105Fenofibrate Combined With Ursodeoxycholic Acid2件: Fenofibrate,
Ursodeoxycholic acid		2件: Fenofibrate ,
Ursodiol 💬 		2件: NR1H4,
PPARA 💬 		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
106Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
107Fenofibrate in Combination With Ursodeoxycholic Acid2件: Fenofibrate,
Ursodeoxycholic acid		2件: Fenofibrate ,
Ursodiol 💬 		2件: NR1H4,
PPARA 💬 		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
108FFP104----2件: 93, 96 💬
109Fully human monoclonal antibody directed against CXCL10----1件: 93 💬
110Fuzhenghuayu----1件: 93 💬
111Genetic: genetic analysis----8件: 34, 85, 90, 93, 94, 96, 234, 265 💬
112GFT505----2件: 93, 94 💬
113GKT137831----2件: 85, 93 💬
114Gold1件: Gold---71件: 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
115GOLEXANOLONE1件: Golexanolone---1件: 93 💬
116GR3027----1件: 93 💬
117GS-9674----2件: 93, 94 💬
118GS-9674 100 mg----1件: 93 💬
119GS-9674 30 mg----1件: 93 💬
120GSK2330672----1件: 93 💬
121GSK2330672/linerixibat 40 mg1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
122GYPP-06 (GKT137831 free base), C10071301-D----1件: 93 💬
123Hesperidin1件: Hesperidin1件: Hesperidin 💬 --3件: 13, 46, 93 💬
124High protein high fiber diet----2件: 93, 95 💬
125ICG----3件: 93, 94, 235 💬
126INT-747----1件: 93 💬
127INT-747, OCA----2件: 93, 94 💬
128IPN60190----2件: 93, 94 💬
129K-808----1件: 93 💬
130K-808 (Dose A)----1件: 93 💬
131K-808 (Dose B)----1件: 93 💬
132Linerixibat1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
133Linerixibat (GSK2330672) 40 mg1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
134Linerixibat (GSK2330672) 45 mg1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
135Linerixibat (GSK2330672) 45mg1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
136LJN452----1件: 93 💬
137LJN452, 0,01 mg----1件: 93 💬
138LJN452, 0,03 mg----1件: 93 💬
139LJN452, 0,1 mg----1件: 93 💬
140LUM001----4件: 93, 94, 297, 338 💬
141LY3009104----10件: 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
142Mabthera®----7件: 13, 35, 43, 44, 46, 63, 93 💬
143Magnesium1件: Magnesium---23件: 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
144MBX 8025----1件: 93 💬
145MBX-8025----3件: 79, 93, 94 💬
146MBX-8025, DSIC----1件: 93 💬
147MBX-8025, Formulation 2----1件: 93 💬
148Methionine1件: Methionine1件: Methionine 💬 --9件: 34, 75, 84, 93, 94, 229, 298, 300, 337 💬
149Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
150Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
151Methylprednisolone and azathioprine2件: Azathioprine,
Methylprednisolone		4件: Azathioprine ,
Methylprednisolone ,
Methylprednisolone acetate ,
Azathioprine sodium 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 93, 95 💬
152Methylprednisolone and Mycophenolate mofetil2件: Methylprednisolone,
Mycophenolate mofetil		4件: Methylprednisolone ,
Mycophenolate mofetil ,
Methylprednisolone acetate ,
Mycophenolate mofetil hydrochloride 💬 		3件: IMPDH1,
IMPDH2,
NR3C1 💬 		3件: Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬2件: 93, 95 💬
153Minodronic acid1件: Minodronic acid---4件: 6, 46, 93, 95 💬
154MODAFINIL1件: Modafinil1件: Modafinil 💬 --6件: 6, 13, 49, 93, 96, 97 💬
155Moexipril1件: Moexipril2件: Moexipril hydrochloride ,
Moexipril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 93 💬
156Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬38件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
157Nalmefene1件: Nalmefene3件: Nalmefene hydrochloride ,
Nalmefene ,
Nalmefene hydrochloride hydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 93 💬
158NCA 500mg----1件: 93 💬
159NGM282----2件: 93, 94 💬
160NI-0801----1件: 93 💬
161Non-myeloablative Hematopoietic Stem Cell Transplantation----1件: 93 💬
162Norucholic acid1件: norUrsodeoxycholic acid1件: Norucholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬2件: 93, 94 💬
163Norucholic acid (NCA) 500 mg----1件: 93 💬
164Norucholic acid (NCA) 500 mgProduct Code: NCA 500mgPharmaceutical Form: Film-coated tabletINN or Proposed INN: Norucholic acidCAS Number: 9697-24-2Current Sponsor code: NCAOther descriptive name: norucholic acidConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 500-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----1件: 93 💬
165Obeticholic Acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬3件: 93, 265, 296 💬
166Obeticholic Acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
167Obeticholic Acid 10 MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
168Obeticholic Acid 5 MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
169Obeticholic Acid Tablets1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
170Obeticholic Acid Tablets(OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
171OCA----3件: 93, 94, 296 💬
172OCA (INT-747)----1件: 93 💬
173OCA, INT-747----1件: 93 💬
174Ocaliva----2件: 93, 296 💬
175Ocaliva 10mg----1件: 93 💬
176Ocaliva 5mg----1件: 93 💬
177Olumiant----9件: 46, 49, 93, 107, 135, 265, 268, 325, 345 💬
178Other: Questionnaire----4件: 85, 93, 94, 106 💬
179Other: Questionnaire, fasting blood sample----2件: 93, 94 💬
180Other: Questionnaire, semen sample, fasting blood sample----2件: 93, 94 💬
181Part 1: LJN452----1件: 93 💬
182Part 2: LJN452 Dose level 1----1件: 93 💬
183Part 2: LJN452 Dose level 2----1件: 93 💬
184Pemafibrate1件: Pemafibrate1件: Pemafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 67, 93 💬
185Pentoxifylline1件: Pentoxifylline1件: Pentoxifylline 💬 --13件: 6, 26, 46, 56, 84, 93, 96, 97, 113, 222, 223, 296, 298 💬
186Potassium1件: Potassium1件: Potassium 💬 --17件: 36, 46, 57, 58, 66, 67, 88, 93, 94, 97, 98, 115, 167, 179, 215, 223, 235 💬
187Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬58件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
188Probiotic----10件: 2, 6, 13, 93, 96, 97, 127, 193, 266, 299 💬
189PVT201----1件: 93 💬
190Pyridoxine1件: Pyridoxine2件: Pyridoxine hydrochloride ,
Pyridoxine 💬 		--5件: 49, 93, 145, 234, 320 💬
191Pyridoxine 10mg1件: Pyridoxine2件: Pyridoxine hydrochloride ,
Pyridoxine 💬 		--1件: 93 💬
192Pyridoxine 10mg BP1件: Pyridoxine2件: Pyridoxine hydrochloride ,
Pyridoxine 💬 		--1件: 93 💬
193Questran----4件: 93, 254, 297, 338 💬
194Raltegravir1件: Raltegravir2件: Raltegravir ,
Raltegravir potassium 💬 		--4件: 13, 26, 93, 265 💬
195RhuDex 100 mg (127 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬 --1件: 93 💬
196RhuDex 25 mg (31.75 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬 --1件: 93 💬
197RhuDex 50 mg (63.5 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬 --1件: 93 💬
198RhuDex choline salt1件: Choline1件: Choline 💬 --1件: 93 💬
199Rifampicin1件: Rifampin2件: Rifampin ,
Rifampicin sodium 💬 		--6件: 6, 13, 17, 46, 93, 299 💬
200Rifaximin1件: Rifaximin1件: Rifaximin 💬 --8件: 6, 65, 93, 96, 97, 99, 296, 299 💬
201Risedronic acid1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬3件: 93, 95, 274 💬
202RITUXIMAB1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
203S-adenosyl-L-methionine1件: Methionine1件: Methionine 💬 --1件: 93 💬
204S-adenosyl-methionine (SAMe) capsules1件: Methionine1件: Methionine 💬 --1件: 93 💬
205Saroglitazar1件: Saroglitazar2件: Saroglitazar ,
Saroglitazar magnesium 💬 		3件: PPARA,
PPARD,
PPARG 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬1件: 93 💬
206SAROGLITAZAR MAGNESIUM2件: Magnesium,
Saroglitazar		2件: Saroglitazar ,
Saroglitazar magnesium 💬 		3件: PPARA,
PPARD,
PPARG 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬1件: 93 💬
207Saroglitazar Magnesium 1 mg2件: Magnesium,
Saroglitazar		2件: Saroglitazar ,
Saroglitazar magnesium 💬 		3件: PPARA,
PPARD,
PPARG 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬1件: 93 💬
208Saroglitazar Magnesium 2 mg2件: Magnesium,
Saroglitazar		2件: Saroglitazar ,
Saroglitazar magnesium 💬 		3件: PPARA,
PPARD,
PPARG 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬1件: 93 💬
209Saroglitazar magnesium 4 mg2件: Magnesium,
Saroglitazar		2件: Saroglitazar ,
Saroglitazar magnesium 💬 		3件: PPARA,
PPARD,
PPARG 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬1件: 93 💬
210SELADELPAR1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬2件: 93, 94 💬
211Seladelpar 10 mg1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
212Seladelpar 10 mg Capsule1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
213Seladelpar 10 mg or less1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
214Seladelpar 5 mg1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
215Seladelpar 5 mg Capsule1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
216Seladelpar 5-10 mg1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
217SETANAXIB1件: Setanaxib---2件: 93, 218 💬
218SETANAXIBProduct Code: GKT137831Pharmaceutical Form: Film-coated tabletINN or Proposed INN: SetanaxibCAS Number: 1218942-37-0Current Sponsor code: GKT137831Other descriptive name: GYPP-06 (GKT137831 free base), C10071301-DConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 400-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----1件: 93 💬
219Sortis----1件: 93 💬
220Sortis 10 mg----1件: 93 💬
221Standard of Care: UDCA----1件: 93 💬
222Standardized meal----2件: 93, 94 💬
223Sublimated mare milk----1件: 93 💬
224T cell injection targeting CD19 chimeric antigen receptor----7件: 46, 49, 51, 53, 63, 93, 300 💬
225TAUROURSODEOXYCHOLIC ACID1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --5件: 2, 28, 93, 299, 302 💬
226Tauroursodeoxycholic Acid Capsules1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --1件: 93 💬
227TDF/FTC/LPV/r----1件: 93 💬
228Tenofovir1件: Tenofovir1件: Tenofovir 💬 --8件: 2, 6, 13, 25, 26, 93, 265, 325 💬
229Tenofovir disoproxil2件: Tenofovir,
Tenofovir disoproxil		4件: Tenofovir disoproxil fumarate ,
Tenofovir ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬 		--3件: 6, 93, 265 💬
230Tetrathiomolybdate1件: Tetrathiomolybdate---3件: 85, 93, 171 💬
231Thiamine1件: Thiamine3件: Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--5件: 8, 13, 93, 265, 340 💬
232Tiamin DAK----2件: 93, 97 💬
233Tiamin SAD----2件: 93, 97 💬
234Tigecycline1件: Tigecycline1件: Tigecycline 💬 --2件: 93, 299 💬
235TQA3526----1件: 93 💬
236Tropifexor1件: Tropifexor1件: Tropifexor 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
237UDCA----2件: 93, 94 💬
238UDCA (Ursodeoxycholic acid)1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
239Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation----2件: 93, 296 💬
240Ursodeoxycholic acid1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬10件: 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
241Ursodeoxycholic Acid (URSO)1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
242Ursodeoxycholic Acid 300mg capsule1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
243Ursodeoxycholic Acid 300mg tablet1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
244Ursodeoxycholic Acid Capsules1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
245Ursodeoxycholic acid combination of immunosuppressive agents1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬2件: 93, 95 💬
246Ursodeoxycholic acid combined with total glucosides of paeony1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
247Ursodeoxycholic acid only1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
248Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)2件: Methylprednisolone,
Ursodeoxycholic acid		3件: Methylprednisolone ,
Ursodiol ,
Methylprednisolone acetate 💬 		2件: NR1H4,
NR3C1 💬 		2件: Bile secretion, Neuroactive ligand-receptor interaction 💬1件: 93 💬
249Ursodeoxycholsäure----1件: 93 💬
250Ursodiol----5件: 8, 20, 93, 234, 299 💬
251Ursofalk----4件: 93, 94, 96, 97 💬
252Ursofalk® 500 mg film-coated tablets----1件: 93 💬
253Ursofalk® 500 mg Filmtabletten----1件: 93 💬
254Ursofalk® capsules----1件: 93 💬
255Ustekinumab1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
256Ustekinumab 180 mg1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 93 💬
257Ustekinumab 45 mg1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 93, 96 💬
258Ustekinumab 90 mg1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬6件: 49, 50, 56, 93, 96, 97 💬
259Vitamin D1件: Vitamin D---26件: 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
260Volixibat1件: Volixibat2件: Volixibat potassium ,
Volixibat 💬 		--2件: 93, 94 💬
261Volixibat potassium2件: Potassium,
Volixibat		3件: Potassium ,
Volixibat potassium ,
Volixibat 💬 		--2件: 93, 94 💬
262VolixibatPharmaceutical Form: Capsule, hardINN or Proposed INN: volixibat potassiumCAS Number: 1431935-92-0Current Sponsor code: VLX, V-0027Other descriptive name: volixibatConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 5-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral useProduct Name: volixibatPharmaceutical Form: Capsule, hardINN or Proposed INN: volixibat potassiumCAS Number: 1431935-92-0Current Sponsor code: VLX, V-0027Other descriptive name: volixibatConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 20-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral use1件: Volixibat2件: Volixibat potassium ,
Volixibat 💬 		--1件: 93 💬
263Zoledronic acid1件: Zoledronic acid5件: Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬16件: 5, 6, 13, 17, 46, 75, 77, 93, 95, 96, 97, 270, 274, 282, 299, 333 💬